25 C
New York

Regeneron says Covid antibody treatment protects for 8 months

Published:


Washington: A synthetic antibody treatment developed by Regeneron reduced the risk of developing symptomatic Covid by more than 80 percent up to eight months after receiving the treatment, the US biotech firm said Monday.

The results are “particularly important to those who do not respond to Covid-19 vaccines including people who are immunocompromised,” said Myron Cohen, a University of North Carolina at Chapel Hill scientist who is leading a government-sponsored study into the treatment.



For Latest Updates Follow us on Google News

**If you have any Query Related This Post then here is the Source Link**

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Recent articles